illuminem logo
illuminem logo
  • Rankings
  • Use Cases
  • Pricing
  • Media
  • More
illuminem logo

About illuminem

AboutCareersBecome a Thought Leader

Advertising

Advertise with usPromote EventsOur Reach

Support

FAQsContact Us
Terms & Privacy Policy

© 2026 illuminem. All rights reserved. Various trademarks held by their owners.

  1. Home
  2. ›
  3. Industries
  4. ›
  5. hospital & health care
  6. ›
  7. Aurinia Pharmaceuticals (AUPH)
Company logo

Aurinia Pharmaceuticals (AUPH) | Sustainability Performance

https://www.auriniapharma.com
Linkedin

Aurinia Pharmaceuticals Inc. develops and commercializes therapies for autoimmune diseases, with a focus on addressing rare and serious conditions. The company emphasizes innovation and patient-centric solutions to improve health outcomes in underserved medical areas.

1993

Canada

201 - 500 employees

Biotechnology

$100M - 500M in revenue

N/A in profitability

Submit or report inaccurate dataDownload Company Insights

Sustainability Ranking & Industry Benchmark

#8425
Overall
#218
in Canada
#174
in Biotechnology

Sustainability Maturity

​​0123456789​​%

Sustainability Intent

Available in
Scale package

Access
​​0123456789​​%

Beyond Top 100

Overview
Environmental
Digital emissionsEnergy consumption
Governance
TargetsESG scores and Exclusions
Financial Data
Business performanceCapital & innovationAnalyst projections

View similiar companies


Company logo
Stemcell Technologies

Canada, Hospital & Health Care, Biotechnology


Company logo
Taproot Community Support Services

Canada, Hospital & Health Care, Hospital & Health Care


Company logo
HealthPRO Canada

Canada, Hospital & Health Care, Hospital & Health Care

Renewable energy

100% 2023
Aligned

Market cap

2.3B $, 2026▲27.2% YoY

Revenue

283.0M $, 2025▲17% YoY

R&D intensity

11.31% 2025

Renewable electricity

Reveal data for 1 credit
100%2023

Industry rank: 8 out of 251


Total electricity consumption
and % renewables
(MWh, % of consumption)

Industry rank: 8 out of 251

Total electricity

Share of renewable electricity

Industry benchmark

Powered by illuminem and GIST Impact

Digital Emissions


CO2e per visit (g)

Industry benchmark

B/M 0.26 g
0 g

Green HostingYes
Download Digital Emissions AnalysisPowered by illuminem and Dedalo AI

Controversy level


Very Low
Low
Noticeable
High
Severe
Download Controversy Analysis
Powered by illuminem

Market cap

2.3B $, 2026▲27.2% YoY

Revenue

283.0M $, FY2025▲17% YoY

EBITDA

104.0M $, FY2025▼9.1% YoY

Operating margin

37% Industry: -370▲105.4% YoY

Revenue & EBITDA

$283.0MFY2025 revenue

Total Annual
Revenue & EBITDA
($ B)

Annual revenue
EBITDA
3 year change
Powered by illuminem

Margin trends


Margin as % of revenue

Gross margin
Operating margin
Net margin

Powered by illuminem

Free cashflow

135.4M 2025▲67.4% YoY

Capex

0.0 2025▼NaN% YoY

Debt/equity ratio

0.1 Industry: 2▼NaN% YoY

R&D intensity

11.3%FY2025

R&D as % of revenue

Return on invested capital (ROIC)
Industry benchmark

Powered by illuminem

Return on invested capital

44.0%FY2026

Return on invested capital (ROIC)
Industry benchmark

Powered by illuminem

Analyst revenue estimates & actuals


Analyst consensus vs actuals
($ B)

Actual revenue
Consensus estimates
Estimate only

0.2

▲ 0.1%

2023

0.2

▼ 0.3%

2024

0.3

▲ 0.8%

2025

0.5

2030

Powered by illuminem

Environmental policy coverage

Carbon reduction policy

Not available

Human rights policy

Not available

Recycling policy

Not available

Workplace health & safety policy

Available

50%
Independent Directors

6 out of 12 incl. management

Powered by illuminem

Overall score

40

Environment

30

Social

39

Governance

51

Exclusion screening

Adult content

Not available

Alcoholic

Not available

Animal testing

Available

Firearms

Not available

Tobacco

Not available

Gambling

Not available

Nuclear

Not available

Powered by illuminem

Reporting

sustainability report symbol

Sustainability Report

Available

Sustainability employees


Total sustainability employees

1



    Available in
    Scale package

    Access
  • Email

  • Email